Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1977 Jun;30(6):510-7.
doi: 10.1136/jcp.30.6.510.

Modification of the microimmunofluorescence test to provide a routine serodiagnostic test for chlamydial infection

Modification of the microimmunofluorescence test to provide a routine serodiagnostic test for chlamydial infection

J D Treharne et al. J Clin Pathol. 1977 Jun.

Abstract

A modification of the microimmunofluorescence test to provide a practicable routine serodiagnostic test for detecting and characterising chlamydial infection is described which uses four antigen pools, one of which corresponds with each of the four main clinical and epidemiological types of chlamydial infection. The three subgroup A Chlamydia (Chlamydia trachomatis) pools are: pool 1, hyperendemic trachoma TRIC agent serotypes A, B, and C; pool 2, paratrachoma TRIC agent serotypes D, E, F, G, H, I, and K; pool 3, lymphogranuloma venereum (LGV) agent serotypes L1, L2, and L3. Pool 4 contained four representative isolates of subgroup B Chlamydia (Chlamydia psittaci). For routine purposes sera need be screened only against these four representative antigen pools. This will detect antibody and indicate which clinical and epidemiological type of chlamydial infection is implicated, thereby clearly distinguishing those infections that are due to C. psittaci. The pattern of the cross-reactions may indicate the individual serotype involved, and further titration requiring a maximum of four individual antigens is sufficient to determine the serotype. The slight loss in sensitivity (twofold) is more than compensated for by the reduction in cost and the tenfold increase in the total number of sera which can be examined.

PubMed Disclaimer

References

    1. J Infect Dis. 1964 Feb;114:1-12 - PubMed
    1. Br J Vener Dis. 1972 Dec;48(6):452-9 - PubMed
    1. J Immunol. 1974 Oct;113(4):1262-70 - PubMed
    1. Trans Ophthalmol Soc U K. 1975 Apr;95(1):16-33 - PubMed
    1. Proc R Soc Med. 1974 Aug;67(8):735-6 - PubMed

Substances

LinkOut - more resources